×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NBP – novabridge biosciences - american depositary shares (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NBP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/16
12:23 pm
nbp
I-Mab (NBP) had its "buy" rating reaffirmed by HC Wainwright. They now have a $9.00 price target on the stock.
Low
Report
I-Mab (NBP) had its "buy" rating reaffirmed by HC Wainwright. They now have a $9.00 price target on the stock.
3/16
07:08 am
nbp
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer [Yahoo! Finance]
Medium
Report
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer [Yahoo! Finance]
3/16
07:00 am
nbp
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
Low
Report
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
3/13
06:05 am
nbp
Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
Medium
Report
Everest Medicines' Licensing Partner NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
3/9
03:38 pm
nbp
NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration Transcript [Seeking Alpha]
Neutral
Report
NovaBridge Biosciences (NBP) Discusses Phase 2a Clinical Data and Development Plan for VIS-101 in Wet Age-Related Macular Degeneration Transcript [Seeking Alpha]
3/9
07:32 am
nbp
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study [Yahoo! Finance]
Low
Report
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study [Yahoo! Finance]
3/9
07:00 am
nbp
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
Low
Report
NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study
3/3
09:39 am
nbp
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 [Yahoo! Finance]
Medium
Report
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
3/16
08:30 am
nbp
Form 6-K NovaBridge Biosciences For: Mar 16
Medium
Report
Form 6-K NovaBridge Biosciences For: Mar 16
3/9
07:05 am
nbp
Form 6-K NovaBridge Biosciences For: Mar 09
Medium
Report
Form 6-K NovaBridge Biosciences For: Mar 09
3/3
09:13 am
nbp
Form 6-K NovaBridge Biosciences For: Mar 03
Medium
Report
Form 6-K NovaBridge Biosciences For: Mar 03
2/25
07:30 am
nbp
Form 6-K NovaBridge Biosciences For: Feb 25
Neutral
Report
Form 6-K NovaBridge Biosciences For: Feb 25
2/19
07:05 am
nbp
Form 6-K NovaBridge Biosciences For: Feb 19
Low
Report
Form 6-K NovaBridge Biosciences For: Feb 19
2/17
04:05 pm
nbp
Form 6-K NovaBridge Biosciences For: Feb 17
Low
Report
Form 6-K NovaBridge Biosciences For: Feb 17
2/6
04:08 pm
nbp
Form 6-K/A NovaBridge Biosciences For: Feb 06
Medium
Report
Form 6-K/A NovaBridge Biosciences For: Feb 06
2/6
08:30 am
nbp
Form 6-K NovaBridge Biosciences For: Feb 06
Medium
Report
Form 6-K NovaBridge Biosciences For: Feb 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: